Schroder Investment Management Group »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Schroder Investment Management Group

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Schroder Investment Management Group from 13F filings

Historical chart of Schroder Investment Management Group investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Schroder Investment Management Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $11M 9.9M 1.11
2024-03-31 $9.3M 9.6M 0.97
2023-12-31 $8.9M 9.6M 0.93

More positions owned by Schroder Investment Management Group

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Booking Holdings (BKNG)
Visa Com Cl A (V)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
JPMorgan Chase & Co. (JPM)
Adobe Systems Incorporated (ADBE)
Merck & Co (MRK)
Anthem (ELV)
Netflix (NFLX)

View all positions for Schroder Investment Management Group

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1